Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research

Author： Bhargava Arpit Mishra Dinesh Banerjee Smita Mishra Pradyumna Kumar

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.21, Iss.2, 2013-02, pp. : 126-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic Cells in Tumor Immunology and Immunotherapy

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 17-39

Bentham Science Publishers

Access to resources Recommend Favorite

MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 344-352

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic cells: immunological features and utilisation for tumour immunotherapy

By Reay Philip A

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 491-506

Informa Healthcare

Access to resources Recommend Favorite

Novel activators of dendritic cells as fundamental tools in immunotherapy

By Gallucci Stefania

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1411-1421

Informa Healthcare

Access to resources Recommend Favorite

Genetically Modified Dendritic Cells for Cancer Immunotherapy

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 619-628

Bentham Science Publishers

Access to resources Recommend Favorite